Navigation Links
Remedy Informatics CEO, Gary Kennedy, to Speak at Molecular Med TRI-CON
Date:2/16/2012

SALT LAKE CITY, Feb. 16, 2012  /PRNewswire/ -- Remedy Informatics, the leading provider of integrated research management systems for Life Science and Translational research, announced that its Founder and CEO, Gary Kennedy, will participate as a speaker in the Integrated R&D Informatics and Knowledge Management Track on Tuesday, Feb. 21, and as an expert panelist on Wednesday, Feb. 22 at Molecular Med TRI-CON Feb. 19-23, 2012, in San Francisco, Calif. (Booth #604).

(Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)

Mr. Kennedy's presentation on Tuesday, titled, "Aggregating & Harmonizing Disparate Data Sources: The Key to Pattern Recognition," will address the fundamental data problems faced by life science and translational researchers – integrating research systems and breaking down silos, generating complete and accurate data sets, and making data accessible with easy-to-use pattern recognition tools. He will also describe how modern ontology-based informatics systems hosted in the cloud can provide a competitive advantage via predictive informatics.

The plenary keynote panel on Wednesday, titled, "Emerging Technologies & Industry Perspectives," will offer conference attendees a look at "emerging and hot technologies in diagnostics, drug discovery and development, informatics, and oncology." A Q&A discussion will also provide attendees an opportunity to interact with panel members.

More information regarding Mr. Kennedy's talk or the expert panel discussion is available on the Molecular Med TRI-CON website, www.triconference.com.

Remedy will also demo Investigate™, the world's first integrated translational research management system at the conference. The product will be featured in the New Product Pavilion at Molecular Med TRI-CON.

"Investigate is designed to improve research efficiencies, facilitate pattern recognition and accelerate discoveries in translational research settings," said Hank Wu, Director of Translational Informatics and Investigate product manager for Remedy.

Investigate is a unique tool available to translational researchers because it integrates next-generation sequencing systems with patient and disease registries and biospecimen management. Researchers benefit from:

  • Aggregation of disparate data types from bench to bedside data sources with an intelligent ontology that harmonizes biospecimen, registry and outcomes data
  • 360 degrees perspective of phenotypic and genotypic data for subjects, patients, diseases
  • Configurability that keeps up with the pace of research, without waiting for software coding or database administration
  • Multi-site, cross disease research collaboration without the cost and complexity of infrastructure building and maintenance
  • A suite of reporting, analysis, and data visualization tools that enable drag-and-drop reporting by researchers, scientists, and clinicians without writing SQL

Investigate was recently selected by SAIC-Frederick, Inc., the operations contractor for the National Cancer Institute's Frederick, Md. campus, as the research informatics platform for ten high profile cancer research laboratories to integrate lab information management systems (LIMS), study design and tracking, patient registries, and data mining and visualization.

Remedy will demonstrate Investigate at BOOTH #604 at the Molecular Med TRI-CON 2012 conference in San Francisco, Calif. beginning Feb. 21 – Feb. 23.

About Remedy Informatics, Inc.

Remedy Informatics, Inc. is the leading provider of clinical registries, integrated research management software, and research informatics products that accelerate translational medicine discoveries from bench to bedside. Remedy offers a wide range of configurable "off the shelf" biomedical informatics products that are built on the powerful Mosaic™ Platform. Remedy's mission is to tangibly, measurably and permanently improve the effectiveness of Life Science and Translational Research in the United States and across the globe.  For more information visit: www.remedyinformatics.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Mike Cummens
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=106822

Gary Kennedy
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=106824

Hank Wu
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=106850

Media Contacts
Kristofer Beldin, Remedy Informatics, (801) 870-9407 (cell), kris.beldin@remedyinformatics.com


'/>"/>
SOURCE Remedy Informatics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
2. Fresenius Medical Care, N.A. Has Selected VitalRemedyMDs VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients
3. Cold-EEZE® Cold Remedy Awarded Coveted Parent Tested Parent Approved (PTPA) Seal of Approval
4. Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign
5. RemedyMD Announces Investigate Cell Therapy, a Revolutionary Research Management System for Blood and Marrow Transplant Centers
6. Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
7. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
8. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
9. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
10. Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials
11. FUJIFILM Establishes Medical Informatics Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... 24, 2016 , ... People across the U.S. are sharpening their pencils and ... essay contest in which patients and their families pay tribute to a genetic counselor ... National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):